A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Subjects With Treatment-resistant Depression
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006873/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of switching elderly
participants with treatment-resistant depression (TRD) from a prior antidepressant treatment
(to which they have not responded) to either intranasal esketamine plus a new oral
antidepressant or switching to a new oral antidepressant plus intranasal placebo.
提供机构：
Vivli
创建时间：
2021-04-15
